We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Fastenal
FAST
$57.8B
| $1.53M | 0.03% |
166,936
+29,824
| +22% | +$296K |
2013 Q2
9 quarters
|
|
227
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
| $1.51M | 0.03% |
65,600
+9,700
| +17% | +$229K |
2014 Q3
4 quarters
|
|
228
Stryker
SYK
$112B
| $1.49M | 0.03% |
15,871
+597
| +4% | +$59.1K |
2013 Q2
9 quarters
|
|
229
FedEx
FDX
$69.9B
| $1.49M | 0.03% |
10,314
+75
| +0.7% | +$12K |
2013 Q2
9 quarters
|
|
230
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $1.48M | 0.03% |
74,568
+22,806
| +44% | +$483K |
2013 Q4
7 quarters
|
|
231
Medtronic
MDT
$122B
| $1.47M | 0.03% |
21,880
+269
| +1% | +$19.8K |
2013 Q2
9 quarters
|
|
|
FULLL
232
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
| $1.44M | 0.03% |
56,300
+6,900
| +14% | +$175K |
2013 Q2
9 quarters
|
|
233
DELISTED
Air Lease Corp
AL
| $1.43M | 0.03% |
46,325
-9,580
| -17% | -$319K |
2014 Q1
6 quarters
|
|
234
Tesla
TSLA
$1.43T
| $1.43M | 0.03% |
86,130
-6,525
| -7% | -$111K |
2013 Q2
9 quarters
|
|
235
Franklin Electric
FELE
$4.45B
| $1.42M | 0.03% |
52,107
+17,149
| +49% | +$492K |
2013 Q2
9 quarters
|
|
236
FirstCash
FCFS
$9.4B
| $1.41M | 0.03% |
35,115
+13,801
| +65% | +$565K |
2014 Q1
6 quarters
|
|
|
PSXP
237
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $1.39M | 0.03% |
28,150
-12,325
| -30% | -$716K |
2014 Q1
6 quarters
|
|
238
iShares Russell 1000 Value ETF
IWD
$83.7B
| $1.38M | 0.03% |
14,821
+4,679
| +46% | +$464K |
2013 Q2
9 quarters
|
|
239
The Mosaic Company
MOS
$6.02B
| $1.36M | 0.03% |
43,647
-575
| -1% | -$23.7K |
2013 Q2
9 quarters
|
|
240
DELISTED
Ansys
ANSS
| $1.34M | 0.03% |
15,260
-630
| -4% | -$57.9K |
2014 Q1
6 quarters
|
|
241
Johnson Controls International
JCI
$89.4B
| $1.32M | 0.03% |
30,493
+9,811
| +47% | +$452K |
2014 Q1
6 quarters
|
|
242
DELISTED
Praxair Inc
PX
| $1.31M | 0.03% |
12,888
+3,239
| +34% | +$357K |
2013 Q2
9 quarters
|
|
243
iShares Europe ETF
IEV
$1.6B
| $1.3M | 0.03% |
32,690
+2,520
| +8% | +$108K |
2014 Q1
6 quarters
|
|
|
AEK.CL
244
DELISTED
Aegon NV
AEK.CL
| $1.3M | 0.03% |
47,166
-1,000
| -2% | -$27.8K |
2013 Q2
9 quarters
|
|
245
Deere & Co
DE
$175B
| $1.3M | 0.03% |
17,526
-195
| -1% | -$17.2K |
2013 Q2
9 quarters
|
|
|
PTR
246
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $1.29M | 0.03% |
18,578
-2,251
| -11% | -$201K |
2013 Q2
9 quarters
|
|
247
DELISTED
Hologic
HOLX
| $1.29M | 0.03% |
33,008
-3,600
| -10% | -$143K |
2014 Q1
6 quarters
|
|
248
Forward Air
FWRD
$535M
| $1.27M | 0.03% |
+30,530
| New | +$1.44M |
2015 Q3
0 quarters
|
|
249
LKQ Corp
LKQ
$5.66B
| $1.27M | 0.03% |
44,635
-2,900
| -6% | -$88.3K |
2013 Q2
9 quarters
|
|
250
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $1.26M | 0.03% |
35,490
+4,540
| +15% | +$174K |
2014 Q1
6 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.